Peter Attia MD#59–Jason Fung, M.D: Fasting as an antidote to obesity, insulin resistance, T2D, & metabolic illness
At a glance
WHAT IT’S REALLY ABOUT
Jason Fung Reframes Insulin Resistance as Overflow and Champions Fasting
- Fung argues the conventional lock-and-key view of insulin resistance cannot explain why insulin still drives fat production, growth, and testosterone effects in the same tissues, and proposes an overflow model where cells are simply too full of glucose.
- He says the problem is hyperinsulinemia rather than resistance, so treatments that add more insulin or sulfonylureas worsen the disease, while approaches that empty the body of glucose, such as SGLT2 inhibitors, low-carb diets and fasting, address the root cause.
- Fung describes fatty liver as the source of insulin resistance and fatty pancreas as the source of beta cell failure, presenting type 2 diabetes as one reversible defect rather than two separate ones.
- He explains how he uses fasting in a busy clinic, individualizing protocols from time-restricted eating to week-long fasts, reporting that he has not had to stop a patient for electrolyte or muscle-loss concerns, while Attia describes a more gradual approach with healthier patients.
- Both speakers criticize the limits of evidence-based medicine and nutritional epidemiology, and Fung argues that for healthy people occasional fasting has a very low risk even though direct evidence of benefit is lacking.
IDEAS WORTH REMEMBERING
5 ideasThe lock-and-key model of insulin resistance has a central paradox
Fung notes that in type 2 diabetes the liver resists insulin's glucose effect yet de novo lipogenesis, growth effects and testosterone effects run overtime, which he says cannot happen if the cell were truly resistant.
Cells may be too full, not locked out
Using the suitcase analogy, Fung says glucose fails to enter a cell either because the door won't open or because it is already full, and he argues the second explanation fits the evidence and implies the solution is emptying the cell.
Giving more insulin treats the symptom and worsens the disease
Fung says sulfonylureas and escalating insulin shove glucose into already full cells, cause weight gain, and explain why tight glucose control trials such as ACCORD, ADVANCE and VADT showed little benefit.
SGLT2 inhibitors support the whole-body glucose idea
Fung points out that these drugs lower A1C only modestly yet reduce kidney and heart risk, which he attributes to removing glucose from the body rather than moving it between compartments.
Fatty liver and fatty pancreas may unify type 2 diabetes
Fung says the liver fat drives hyperinsulinemia and the fat-clogged pancreas explains beta cell failure, so both are reversible with fasting, which he cites alongside bariatric surgery results and Roy Taylor's work.
WORDS WORTH SAVING
5 quotesThe whole point of evidence-based medicine is that it's not a search for truth, it's a search for consensus.
— Dr. Jason Fung
The problem is not insulin resistance per se. The problem is hyperinsulinemia.
— Dr. Jason Fung
We kept putting more shirts in when we should have been taking shirts out.
— Dr. Jason Fung
It's like storing firewood for the winter, and then as soon as you need to use it, you chop up your sofa and throw it in the fire. Like, who would do that?
— Dr. Jason Fung
I find that the people who are super dogmatic are the people who never see patients.
— Dr. Jason Fung
High quality AI-generated summary created from speaker-labeled transcript.
